Hadassah

Oral Insulin Pill, Based on Hadassah Medical Center Research, Cleared by FDA for Clinical Trial in US

Tuesday, May 21 2013

The oral insulin pill (ORMD-0801), based on over 30 years of research by Hadassah Medical Center scientists, and developed by the Israeli company, Oramed Pharmaceuticals Inc., has been cleared by the United States Food and Drug Administration (FDA) for Phase 2 clinical trials in the US.

The orally ingestible capsule is indicated for those with early stage type two diabetes, when it can slow the rate of disease progression by providing additional insulin to the body and allowing the pancreas a respite. The pill delivery system has the advantage of mimicking insulin's natural location and gradients in the body by first passing through the liver before entering the bloodstream. "We are very pleased to have the FDA clearance to proceed," stated Nadav Kidron, Chief Executive Officer of Oramed. "The upcoming trial is a major milestone for Oramed and we look forward to continuing to progress ORMD-0801's clinical development in the US."

Read more about the insulin pill from Hadassah International>>

Related Stories

alt_text

Thursday, Oct 17 2019

Where are we with Alzheimer’s? Hadassah Doctor Provides His Perspective

With the chance that any one of us could acquire Alzheimer’s disease doubling every five years after age 60, Prof. Tamir Ben-Hur...

READ MORE ›
alt_text

Thursday, Oct 17 2019

Three More Years: An Unprecedented Extension of Life

Gerald Lieder, age 94, passed away this month. Three years ago, his family gathered from the United States and Israel to say goodbye to him because his heart was failing.

READ MORE ›
alt_text

Thursday, Oct 17 2019

Hadassah Study Sheds Encouraging Light in Treating Liver Disease

The International Journal of Molecular Medicine has published a pre-clinical study led by Prof. Rifaat Safadi, head of the Hadassah Medical Organization’s Liver Unit...

READ MORE ›
alt_text

Thursday, Oct 17 2019

Vaginal Microbiome Transplant Proves Effective Against Bacterial Vaginosis

A new treatment developed by Hadassah Medical Organization and Weizmann Institute of Science researchers, involving a vaginal microbiome transplant...

READ MORE ›
SUPPORT HADASSAH HOSPITALS

Learn more about the Hadassah Medical Organization.

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More